Stoky
Back to explore
N
NoahListening
A
AshListening
0:00 / 0:00I. Financial Results and Performance
SOLV logo

Solventum Achieves 2.1% Organic Growth Amid $4 Billion Divestiture and Spin-Off Transition

SOLV10-QFiling Date: 5/5/2026
Solventum Corporation
Description

What this story covers

Solventum navigates its 3M spin-off with 2.1% organic growth despite a 3% reported sales decline following a major divestiture. While restructuring costs and litigation persist, robust liquidity and a $1 billion buyback program signal long-term strategic resilience.

Story snapshot

CompanySolventum Corporation
TickerSOLV
VariantStandard detailed
Duration12:02
Filing type10-Q
PeriodQ1 2026
IndustryHealthcare & Pharmaceuticals
Accession0001964738-26-000024
Sources1

Full Story Script

Content not available for this story.

Primary Sources

sec_filing10-QView on SEC.gov →

Ask Noah

Question the story, source filings, and key financial signals.

Sign in to chat with Noah

Ask questions about revenue, margins, risk factors, filings and more. Noah uses retrieval-augmented analysis over raw financial disclosures.

Sign in